A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

NCT07252375 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

35

Enrollment

OTHER_GOV

Sponsor class

Conditions

Nasopharyngeal Carcinoma (NPC)
CTIT-Chemotherapy Induced Thrombocytopenia

Interventions

DRUG: herombopag olamine tablets

Sponsor

Fujian Cancer Hospital